[go: up one dir, main page]

DE60023859D1 - Verfahren zur herstellung von amin-platin-komplexen - Google Patents

Verfahren zur herstellung von amin-platin-komplexen

Info

Publication number
DE60023859D1
DE60023859D1 DE60023859T DE60023859T DE60023859D1 DE 60023859 D1 DE60023859 D1 DE 60023859D1 DE 60023859 T DE60023859 T DE 60023859T DE 60023859 T DE60023859 T DE 60023859T DE 60023859 D1 DE60023859 D1 DE 60023859D1
Authority
DE
Germany
Prior art keywords
amin
producing
platinum complexes
complexes
platinum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023859T
Other languages
English (en)
Other versions
DE60023859T2 (de
Inventor
S Wong
M Giandomenico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DE60023859D1 publication Critical patent/DE60023859D1/de
Publication of DE60023859T2 publication Critical patent/DE60023859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60023859T 1999-04-13 2000-04-11 Verfahren zur herstellung von amin-platin-komplexen Expired - Lifetime DE60023859T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12893999P 1999-04-13 1999-04-13
US128939P 1999-04-13
PCT/CA2000/000385 WO2000061590A1 (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes

Publications (2)

Publication Number Publication Date
DE60023859D1 true DE60023859D1 (de) 2005-12-15
DE60023859T2 DE60023859T2 (de) 2006-08-03

Family

ID=22437722

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023859T Expired - Lifetime DE60023859T2 (de) 1999-04-13 2000-04-11 Verfahren zur herstellung von amin-platin-komplexen

Country Status (32)

Country Link
US (1) US6518428B1 (de)
EP (1) EP1165576B1 (de)
JP (1) JP4756669B2 (de)
KR (1) KR100711955B1 (de)
CN (3) CN100460412C (de)
AR (1) AR043084A1 (de)
AT (1) ATE309257T1 (de)
AU (1) AU770006B2 (de)
BG (1) BG65429B1 (de)
BR (1) BR0009780B1 (de)
CA (1) CA2368849C (de)
CY (1) CY1104965T1 (de)
CZ (1) CZ303156B6 (de)
DE (1) DE60023859T2 (de)
DK (1) DK1165576T3 (de)
EE (1) EE04747B1 (de)
ES (1) ES2253214T3 (de)
HK (2) HK1039336B (de)
HU (1) HUP0200748A3 (de)
IL (1) IL145671A0 (de)
IS (1) IS2711B3 (de)
MX (1) MXPA01010430A (de)
MY (1) MY122706A (de)
NO (1) NO330429B1 (de)
NZ (1) NZ514736A (de)
PL (1) PL202731B1 (de)
RU (1) RU2245340C2 (de)
SK (1) SK286374B6 (de)
TW (1) TWI289565B (de)
UA (1) UA71614C2 (de)
WO (1) WO2000061590A1 (de)
ZA (1) ZA200107965B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
NZ514736A (en) 1999-04-13 2004-01-30 Anormed Inc Process for preparing amine platinum complexes
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
US20080058411A1 (en) 2004-02-18 2008-03-06 Gpc Biotech Ag Methods For Treating Resistant Or Refractory Tumors
CZ296459B6 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
US20100310661A1 (en) * 2007-07-16 2010-12-09 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
CA2715348A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
US20120123121A1 (en) * 2009-06-12 2012-05-17 Poniard Pharmaceuticals, Inc. Synthesis of picoplatin
RU2451010C1 (ru) * 2011-01-11 2012-05-20 Закрытое Акционерное Общество "Ива Фарм" Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия
CN103554188B (zh) * 2013-11-19 2016-03-02 辽宁大学 6-(氮杂环取代)蒽醌二氯化铂配合物及其制备方法和应用
CN103860539B (zh) * 2014-04-14 2016-02-10 于迎涛 一种具有混合轴向配体的Pt（IV）类抗癌药物及制备方法
CN104231000A (zh) * 2014-08-20 2014-12-24 山东铂源药业有限公司 一种抗肿瘤药物甲啶铂的合成方法
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (ko) * 2019-08-05 2020-07-27 한국과학기술연구원 메탄올 또는 그 전구체 합성용 촉매, 이의 제조방법 및 이를 이용한 메탄올 또는 그 전구체의 제조방법
AU2021306808A1 (en) 2020-07-08 2023-02-02 Pharma& Schweiz Gmbh Satraplatin for use in the treatment of lymphoid neoplasms
CN113402565B (zh) * 2021-06-16 2023-07-28 中国人民解放军空军军医大学 一类含有泊沙康唑的四价铂配合物、制备方法及其应用
WO2023131524A1 (en) 2022-01-07 2023-07-13 Dayton Therapeutics Ag Treating haematological malignancies by means of satraplatin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA805101B (en) * 1979-08-23 1981-08-26 Johnson Matthey Co Ltd Compositions containing platinium
US4533502A (en) 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
EP0167310B1 (de) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Platinkoordinationsverbindungen
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
CZ20013307A3 (cs) 1999-03-19 2002-05-15 Anormed Inc. Farmaceutické kompozice obsahující komplexy kovů
NZ514736A (en) 1999-04-13 2004-01-30 Anormed Inc Process for preparing amine platinum complexes

Also Published As

Publication number Publication date
ES2253214T3 (es) 2006-06-01
MY122706A (en) 2006-04-29
CN1916009A (zh) 2007-02-21
NO330429B1 (no) 2011-04-11
KR100711955B1 (ko) 2007-05-02
AR043084A1 (es) 2005-07-20
CZ303156B6 (cs) 2012-05-09
IS2709B (is) 2011-01-15
CN1350540A (zh) 2002-05-22
KR20020018189A (ko) 2002-03-07
CN1250559C (zh) 2006-04-12
TWI289565B (en) 2007-11-11
AU3951000A (en) 2000-11-14
JP2002541263A (ja) 2002-12-03
AU770006B2 (en) 2004-02-12
BG106090A (en) 2002-06-28
EP1165576A1 (de) 2002-01-02
NO20014957D0 (no) 2001-10-12
CA2368849A1 (en) 2000-10-19
HK1039336A1 (en) 2002-04-19
SK286374B6 (sk) 2008-08-05
SK14682001A3 (sk) 2002-01-07
HUP0200748A2 (hu) 2002-07-29
US6518428B1 (en) 2003-02-11
HK1100562A1 (en) 2007-09-21
ZA200107965B (en) 2003-01-02
EE04747B1 (et) 2006-12-15
CY1104965T1 (el) 2010-03-03
EE200100536A (et) 2003-02-17
ATE309257T1 (de) 2005-11-15
CN100460412C (zh) 2009-02-11
IS6092A (is) 2001-09-28
JP4756669B2 (ja) 2011-08-24
PL351612A1 (en) 2003-05-05
CN1847253A (zh) 2006-10-18
IL145671A0 (en) 2002-06-30
CZ20013648A3 (cs) 2002-02-13
DK1165576T3 (da) 2006-03-27
CN1916009B (zh) 2010-12-15
HK1039336B (zh) 2006-01-27
MXPA01010430A (es) 2002-03-27
NZ514736A (en) 2004-01-30
IS2711B3 (is) 2011-01-15
UA71614C2 (en) 2004-12-15
BR0009780B1 (pt) 2013-09-24
RU2245340C2 (ru) 2005-01-27
WO2000061590A1 (en) 2000-10-19
DE60023859T2 (de) 2006-08-03
HUP0200748A3 (en) 2010-01-28
BG65429B1 (bg) 2008-07-31
BR0009780A (pt) 2002-01-02
EP1165576B1 (de) 2005-11-09
NO20014957L (no) 2001-12-03
PL202731B1 (pl) 2009-07-31
CA2368849C (en) 2011-01-25

Similar Documents

Publication Publication Date Title
DE60023859D1 (de) Verfahren zur herstellung von amin-platin-komplexen
DE60005779D1 (de) Verfahren zur herstellung von polyarylaten
DE69913666D1 (de) Verfahren zur herstellung von di-methyl-naphthalinen
DE50010110D1 (de) Verfahren zur herstellung von plattenförmigen produkten
DE69911398D1 (de) Verfahren zur herstellung von 4-aminodiphenylaminen
ATE258157T1 (de) Verfahren zur herstellung von 3-hydroxypropanal
DE69906593D1 (de) Verfahren zur herstellung von 8-chinolinolato metallkomplexen
DE69934332D1 (de) Verfahren zur herstellung von polyolefinen
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
DE60006219D1 (de) Kontinuierliches verfahren zur herstellung von diacetoxybuten
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
DE69910995D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE60010683D1 (de) Verfahren zur herstellung von polyketonen
DE69934334D1 (de) Verfahren zur herstellung von polyolefinen
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
EP1208106A4 (de) Verfahren zur herstellung von aminopropyl- oder aminoalkyl-unktionalisierten polyalkyl- oder aryl-siloxanen
DE60001902D1 (de) Verfahren zur herstellung titankomplexen
DE69934913D1 (de) Verfahren zur herstellung von funktionalisierten polyphenylenethern
DE50002226D1 (de) Verfahren zur herstellung von n-phosphonomethylglycin
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen
DE50006598D1 (de) VERFAHREN ZUR HERSTELLUNG VON CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)
DE60008710D1 (de) Verfahren zur herstellung von carbonylfluorid
DE69901192D1 (de) Verfahren zur herstellung von cyclopropanmethylamin
ATA45299A (de) Verfahren zur herstellung von oxcarbazepin
DE60011427D1 (de) Verfahren zur herstellung von 2-pyridylpiperidin-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition